Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
53 studies found for:    "Secernentea Infections"
Show Display Options
Rank Status Study
1 Withdrawn Pediatric Pharmacokinetics And Safety Study Of Moxidectin
Condition: Onchocerciasis
Intervention: Drug: moxidectin
2 Completed Effect of Albendazole Dose on Clearance of Filarial Worms
Conditions: Lymphatic Filariasis;   Wuchereria Bancrofti Infection
Intervention: Drug: DEC/Albendazole
3 Active, not recruiting Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children
Conditions: Intestinal Helminthiasis;   Ascariasis;   Hookworm;   Malaria
Interventions: Drug: Albendazole;   Dietary Supplement: Vitamin C
4 Unknown  Treatment of Asymptomatic Toxocariasis With Albendazole in Children
Condition: Asymptomatic Toxocariasis
Interventions: Drug: Albendazole;   Drug: Placebo
5 Completed Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
Conditions: Ascariasis;   Trichuriasis;   Hookworm Infection;   Strongyloidiasis;   Pediculosis
Intervention: Drug: albendazole vs. combined albendazole/ivermectin treatment
6 Completed Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection
Condition: Onchocerciasis
Interventions: Drug: 2 mg moxidectin;   Drug: ivermectin 150 mcg/kg;   Drug: 4 mg moxidectin;   Drug: 8 mg moxidectin
7 Unknown  Management of Soil-transmitted Helminthiasis and Strongyloidiasis
Conditions: Helminthiasis;   Strongyloides Stercoralis Infection
Intervention: Drug: Ivermectin + Albendazole
8 Terminated Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
Condition: Hookworm Infection
Intervention: Biological: Na-ASP-2 Hookworm Vaccine
9 Completed Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
Condition: Hookworm Infection
Interventions: Biological: Na-ASP-2/Alhydrogel Hookworm Vaccine;   Biological: Saline placebo
10 Not yet recruiting Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
Conditions: Mansonella Perstans Infection;   Buruli Ulcer;   Tuberculosis;   Co-infection
Intervention: Drug: Doxycycline
11 Recruiting Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin MDA
12 Completed Study of Patients With Strongyloides Stercoralis Infection
Conditions: HIV Infection;   Nematode Infection;   Strongyloidiasis
13 Recruiting Does Treating Hookworm Improve Productivity of Small Subsistence Farmers
Conditions: Hookworm Stool Burden;   Anemia;   Exercise Tolerance
Interventions: Drug: albendazole;   Drug: placebo
14 Completed Medical Implications of Coinfection With Malaria and Filariasis Parasites
Conditions: Malaria;   Filariasis
15 Unknown  Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi
Condition: Lymphatic Filariasis
Interventions: Drug: Albendazole 400mg and ivermectin 200mcg/kg;   Drug: Albendazole and ivermectin;   Drug: albendazole 800mg and ivermectin 400mcg/kg bi-annually
16 Completed Study to Test Whether Shoes Protect Children Against Hookworm Infection on Pemba Island, Zanzibar
Condition: Hookworm
Intervention: Device: Shoes
17 Completed Research for Elimination of Lymphatic Filariasis (ICIDR)
Condition: Lymphatic Filariasis
18 Recruiting Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
Condition: Lymphatic Filariasis
Interventions: Drug: Diethylcarbamazine;   Drug: Albendazole;   Drug: Ivermectin
19 Not yet recruiting Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults
Conditions: Hookworm Infection;   Hookworm Disease
Interventions: Biological: Na-APR-1 (M74)/Alhydrogel®;   Biological: Na-GST-1/Alhydrogel®;   Biological: Hepatitis B vaccine
20 Active, not recruiting Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
Conditions: Hookworm Infection;   Hookworm Disease
Interventions: Biological: Na-APR-1 (M74)/Alhydrogel®;   Biological: Gluco-Pyranosylphospho-Lipid A Aqueous Formulation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years